164 related articles for article (PubMed ID: 1707604)
1. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
Smith MS; Thresher RJ; Pagano JS
Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
[TBL] [Abstract][Full Text] [Related]
2. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
Hansen BD; Nara PL; Maheshwari RK; Sidhu GS; Bernbaum JG; Hoekzema D; Meltzer MS; Gendelman HE
J Virol; 1992 Dec; 66(12):7543-8. PubMed ID: 1279206
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
4. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
[TBL] [Abstract][Full Text] [Related]
5. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.
Fernie BF; Poli G; Fauci AS
J Virol; 1991 Jul; 65(7):3968-71. PubMed ID: 1710293
[TBL] [Abstract][Full Text] [Related]
6. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.
Vendrame D; Sourisseau M; Perrin V; Schwartz O; Mammano F
J Virol; 2009 Oct; 83(20):10527-37. PubMed ID: 19706714
[TBL] [Abstract][Full Text] [Related]
7. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
Agy MB; Acker RL; Sherbert CH; Katze MG
Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
[TBL] [Abstract][Full Text] [Related]
8. Effects of IFN alpha on late stages of HIV-1 replication cycle.
Dianzani F; Castilletti C; Gentile M; Gelderblom HR; Frezza F; Capobianchi MR
Biochimie; 1998; 80(8-9):745-54. PubMed ID: 9865497
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1.
Yasuda Y; Miyake S; Kato S; Kita M; Kishida T; Kimura T; Ikuta K
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1046-51. PubMed ID: 2213506
[TBL] [Abstract][Full Text] [Related]
10. Analysis of nonproductive human immunodeficiency virus type 1 infection of human fetal dorsal root ganglia glial cells.
Kunsch C; Wigdahl B
Intervirology; 1990; 31(2-4):147-58. PubMed ID: 1695619
[TBL] [Abstract][Full Text] [Related]
11. Anoxia induces human immunodeficiency virus expression in infected T cell lines.
Polonis VR; Anderson GR; Vahey MT; Morrow PJ; Stoler D; Redfield RR
J Biol Chem; 1991 Jun; 266(18):11421-4. PubMed ID: 1904863
[TBL] [Abstract][Full Text] [Related]
12. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells.
Han X; Becker K; Degen HJ; Jablonowski H; Strohmeyer G
Eur J Clin Invest; 1996 Apr; 26(4):286-92. PubMed ID: 8732485
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
Puddu P; Locardi C; Sestili P; Varano F; Petrini C; Modesti A; Masuelli L; Gresser I; Belardelli F
J Virol; 1991 May; 65(5):2245-53. PubMed ID: 1901915
[TBL] [Abstract][Full Text] [Related]
14. Modification of human immunodeficiency viral replication by pine cone extracts.
Lai PK; Donovan J; Takayama H; Sakagami H; Tanaka A; Konno K; Nonoyama M
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):205-17. PubMed ID: 1691654
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
[TBL] [Abstract][Full Text] [Related]
17. Restriction of HIV-1 replication in promonocytic cells: a role for IFN-alpha.
Macé K; Duc Dodon M; Gazzolo L
Virology; 1989 Feb; 168(2):399-405. PubMed ID: 2492697
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties.
Balachandran R; Thampatty P; Enrico A; Rinaldo C; Gupta P
Virology; 1991 Jan; 180(1):229-38. PubMed ID: 1701946
[TBL] [Abstract][Full Text] [Related]
19. Effect of cloned human interferon-alpha 2a on bovine parainfluenza-3 virus. Brief report.
Panigrahi P; Mohanty SB; Maheshwari RK; Friedman RM
Arch Virol; 1988; 98(1-2):107-15. PubMed ID: 2829793
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells.
Dubreuil M; Sportza L; D'Addario M; Lacoste J; Rooke R; Wainberg MA; Hiscott J
Virology; 1990 Nov; 179(1):388-94. PubMed ID: 1699354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
